Mydecine Innovations Group, Inc. (TSE:MYCO) has released an update.
Mydecine Innovations Group Inc. has recently completed a share for debt settlement, issuing over 2.9 million shares to partially clear a $50,000 debt with a creditor for legal services. The shares, issued at a price of $0.017 each, are expected to be admitted for trading on the Aquis Stock Exchange around early April 2024. With this settlement, Mydecine aims to strengthen its financial position by reducing liabilities and aligning its share capital with its growth strategy.
For further insights into TSE:MYCO stock, check out TipRanks’ Stock Analysis page.
